In addition, a previous study [20] investigated the association between serum tumor markers (including NSE, CEA and CYFRA21-1) and the metabolic tumor volume (MTV) or total lesion glycolysis (TLG) determined by 18F-FDG PET/CT in patients with recurrent SCLC. This evidence concerns the gene ENO2 and neoplasm.